Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Reducing drug toxicity and costs through off-label dosing.
Chemoprevention of arsenic-induced skin cancer
A critical review of ozanimod for the treatment of adults with moderately to severely active ulcerative colitis.
Inflammatory Bowel Disease and the Risk of Prostate Cancer.
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease.
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2025 Feb 25; 1-16.
View in:
PubMed
authors with profiles
Stephen B. Hanauer